Kepler Capital Sticks to Its Hold Rating for Sanofi (SNYNF)
J.P. Morgan Sticks to Its Hold Rating for Sanofi (SNYNF)
Sanofi (SNYNF) Gets a Sell From Deutsche Numis
UBS Sticks to Their Buy Rating for Sanofi (SNYNF)
Jefferies Remains a Buy on Sanofi (SNYNF)
J.P. Morgan Sticks to Its Hold Rating for Sanofi (SNYNF)
Berenberg Bank Reaffirms Their Buy Rating on Sanofi (SNYNF)
Wedbush Adjusts Price Target on Vigil Neuroscience to $23 From $22 on Heels of Sanofi Investment, Maintains Outperform Rating
Analysts Offer Insights on Healthcare Companies: Veeva Systems (VEEV), Gilead Sciences (GILD) and Sanofi (OtherSNYNF)
Analysts Offer Insights on Healthcare Companies: Zimmer Biomet Holdings (ZBH), Cellectis SA (CLLS) and Sanofi (OtherSNYNF)
Analysts Are Bullish on Top Healthcare Stocks: Sanofi (SNYNF), Agios Pharma (AGIO)
Strong Buy Rating for Sanofi on Dupixent's Expansion and Pipeline Potential
Buy Rating Reaffirmed for Fulcrum Therapeutics Amid Sanofi Partnership and Promising Drug Prospects
Buy Rating Affirmed for Fulcrum Therapeutics: Licensing Deal With Sanofi and Promising Phase 3 Study
Buy Rating for Sanofi: Strong Growth and Attractive Valuation Amidst Pipeline Optionality and Strategic Leadership
Buy Rating Upheld for Fulcrum Therapeutics Amid Sanofi Partnership and Upcoming Trial Catalysts
Analysts Offer Insights on Healthcare Companies: Structure Therapeutics, Inc. Sponsored ADR (GPCR), 4D Molecular Therapeutics (FDMT) and Sanofi (OtherSNYNF)
Analysts' Opinions Are Mixed on These Healthcare Stocks: Oncolytics Biotech (ONCY), Aveanna Healthcare Holdings (AVAH) and Sanofi (OtherSNYNF)
Buy Rating for Novavax Amid Strategic Sanofi Partnership and Solid Financial Prospects
UBS Reaffirms Their Buy Rating on Sanofi (SNYNF)